SAVITRI

EUIPO EUIPO 2024 Application published

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark SAVITRI was filed as Word mark on 03/28/2024 at the European Union Intellectual Property Office. The current status of the mark is "Application published".

Trademark Details Last update: May 14, 2024

Trademark form Word mark
File reference 019005936
Application date March 28, 2024
Publication date May 13, 2024

Trademark owner

12780 El Camino Real
92130 San Diego,
US

Trademark representatives

Prinsenkade 9D 4811 VB Breda NL

goods and services

42 Pharmaceutical research and development services; conducting clinical trials for others for pharmaceutical preparations; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; pharmaceutical research and development services in the field of major depressive disorder and neurological, central nervous system, psychiatric, and mood disorders; conducting clinical trials for others for pharmaceutical preparations for the treatment and prevention of major depressive disorder and neurological, central nervous system, psychiatric, and mood disorders; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations for the treatment and prevention of major depressive disorder and neurological, central nervous system, psychiatric, and mood disorders, and evaluating epidemiological results for treatments for major depressive disorder and neurological, central nervous system, psychiatric, and mood disorders; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials pertaining to therapies and treatments for major depressive disorder and neurological, central nervous system, psychiatric, and mood disorders
44 Providing medical information; providing medical information relating to therapies and treatments for major depressive disorder and neurological, central nervous system, psychiatric, and mood disorders

ID: 11019005936